Li, Yuchun
Huang, Yingjuan
Chen, Renqiang
Huang, Weizhen
Xu, Huanzhi
Ye, Rongshen
Huang, Shaoling
Zhen, Ji
Wen, Xiaodan
Wang, Guoyi
Liu, Yong
Li, Haishan
Zheng, Zaichun
Wang, Jian
Wang, Guoshen
Chen, Chong
Zeng, Wen
Meng, Feng
Huang, Xiaoming
Wang, Guangze
Yang, Bing
Chen, Yan
Funding for this research was provided by:
Bill and Melinda Gates Foundation (No. INV-018913)
Hainan Provincial Basic and Applied Basic Research Program (Natural Science Foundation) for High-level Talents in 2019 (2019RC394)
Natural Science Foundation of China (81460520)
Article History
Received: 18 January 2022
Accepted: 12 August 2022
First Online: 14 September 2022
Declarations
:
: This study was approved by the Hainan Provincial Health and Family Planning Commission (ID: 201536, 201603, 201714, 201711). Informed consent was signed by the participants who taking piperaquine. The researchers informed medication procedure, adverse reactions, and the purpose of the medication.
: Not applicable.
: The authors declare no competing interests.